Profile picture

Doctor Anca Daniela Farcas

University of Medicine and Pharmacy of Cluj Napoca, Cluj Napoca (Romania)
Follow
Logo ESC

Contributor content

Could diastolic perfomance parameters be earlier markers for cardiotoxicity in high risk cancer patients?
Presentation
Could diastolic perfomance parameters be earlier markers for cardiotoxicity in high risk cancer patients?
Read more
The role of ST2 as an early marker of endothelial dysfunction in hypertensive patients
Presentation
The role of ST2 as an early marker of endothelial dysfunction in hypertensive patients
Read more
Plasma levels of ST2 - predictive factor of unfavourable outcome in hypertensive patients
Presentation
Plasma levels of ST2 - predictive factor of unfavourable outcome in hypertensive patients
Read more
Heart failure with mid-range ejection fraction - an echocardiographic finding or a clinical phenotype?
Presentation
Heart failure with mid-range ejection fraction - an echocardiographic finding or a clinical phenotype?
Read more
Metoprolol and carvedilol in heart failure - different mechanisms, similar effect?
Presentation
Metoprolol and carvedilol in heart failure - different mechanisms, similar effect?
Read more
Improving blood pressure control beyond the guidelines
Presentation
Improving blood pressure control beyond the guidelines
Read more
The lymphocyte count and neutrophil/lymphocyte ratio as independent predictors for cardiac events in heart failure only in ischemic heart disease patients
Presentation
The lymphocyte count and neutrophil/lymphocyte ratio as independent predictors for cardiac events in heart failure only in ischemic heart disease patients
Read more

ESC 365 is supported by

novartis Explore sponsored resources